CLINICAL PROGNOSTIC CRITERIA FOR LATER DIAGNOSIS OF PROSTATE CARCINOMA IN PATIENTS WITH INITIAL ISOLATED PROSTATIC INTRAEPITHELIAL NEOPLASIA

Citation
Ar. Zlotta et al., CLINICAL PROGNOSTIC CRITERIA FOR LATER DIAGNOSIS OF PROSTATE CARCINOMA IN PATIENTS WITH INITIAL ISOLATED PROSTATIC INTRAEPITHELIAL NEOPLASIA, European urology, 30(2), 1996, pp. 249-255
Citations number
30
Categorie Soggetti
Urology & Nephrology
Journal title
ISSN journal
03022838
Volume
30
Issue
2
Year of publication
1996
Pages
249 - 255
Database
ISI
SICI code
0302-2838(1996)30:2<249:CPCFLD>2.0.ZU;2-M
Abstract
Prostatic intraepithelial neoplasia (PIN) is considered as a precursor of prostate cancer and is frequently associated with it. Diagnosis of PIN on a prostate needle biopsy without associated carcinoma is a dif ficult problem since high-grade PIN does not necessarily mean that pro state cancer is always present and low-grade PIN is associated with ca ncer as well. Definition of parameters predictive of the later finding of prostate cancer on repeat biopsy in patients with PIN is of eviden t interest and we have reviewed our experience and recent data from th e literature on this topic. High grade is a strong predictor of later cancer found on repeat biopsy (50-100%) and in these patients, serum p rostate-specific antigen (PSA), digital rectal examination and transre ctal ultrasound are predictors of later cancer found on repeat biopsy. High-grade PIN is, however, frequently associated with later cancer w hatever PSA, even when less than or equal to 4 ng/ml. Low-grade PIN se ems to behave like BPH since the incidence of later cancer is extremel y low when PSA is <4 ng/ml and is high when PSA >10 ng/ml. Patients wi th high-grade PIN should systematically be rebiopsied after 3-6 months to exclude cancer because they are likely to have undiagnosed cancer. Patients with low-grade PIN and low PSA seem to have a low risk of la ter cancer found on repeat biopsy. Patients with low-grade PIN and hig h serum PSA should have repeat biopsies because the incidence of subse quent cancer is high and comparable to high-grade PIN. Further investi gations are needed to optimize the management of patients with low-gra de PIN and intermediate PSA level.